首页> 美国卫生研究院文献>Translational Lung Cancer Research >Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations

【2h】

Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations

机译：Exon 20 YVMA插入与高级非小细胞肺癌患者的高脑转移和化疗的低发生率与HER2激酶结构域突变有关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Translational Lung Cancer Research
作者
Shuo Yang; Yan Wang; Chao Zhao; Xuefei Li; Qian Liu; Shiqi Mao; Yiwei Liu; Xiaofei Yu; Wanying Wang; Qinrun Tian; Yingying Pan; Anwen Xiong; Bin Chen; Guanghui Gao; Wei Li; Yayi He; Fengying Wu; Xiaoxia Chen; Chunxia Su; Shengxiang Ren; Caicun Zhou;
展开▼
作者单位

展开▼
年(卷),期 2021(10),2
年度 2021
页码 753–765
总页数 13
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
HER2;

机译：HER2.;

相似文献

外文文献
中文文献
专利

1. EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study [J] . Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2020,第期

机译：EGFR外显子20插入中华高级非小型细胞肺癌患者的突变：全国性研究的分子异质性和治疗结果
2. Sensitive methods for the detection of an insertion in exon 20 of the HER2 gene in the metastasis of non-small cell lung cancer to the central nervous system [J] . KrawczykP., Nico?M., PowrózekT., Oncology letters . 2013,第4期

机译：检测非小细胞肺癌向中枢神经系统转移中HER2基因外显子20插入的灵敏方法
3. Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation [J] . ParkS.J., KimH.T., LeeD.H., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2012,第3期

机译：表皮生长因子受体酪氨酸激酶抑制剂对具有外显子19或21外显子突变的非小细胞肺癌患者脑转移的疗效
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Predictors of changes in health-related quality of life during chemotherapy in an advanced non-small cell lung cancer patient population [D] . Shallwani, Shirin Mehdi 2010

机译：非小细胞肺癌晚期患者化疗期间健康相关生活质量变化的预测因子
6. Tumor genomics and response to chemotherapy in advanced non-small cell lung cancer with exon 20 insertion epidermal growth factor receptor mutations [O] . Yue Wang, Jingwen Li, Yan Zhou, 2020

机译：外显子20插入表皮生长因子受体突变肿瘤基因组学与晚期非小细胞肺癌中疗的反应
7. Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations [O] . Shuo Yang, Yan Wang, Chao Zhao, 2021

机译：Exon 20 YVMA插入与高级非小细胞肺癌患者的高脑转移和化疗的低发生率与HER2激酶结构域突变有关

Exon 20 YVMA insertion is associated with high incidence of brain metastasis and inferior outcome of chemotherapy in advanced non-small cell lung cancer patients with HER2 kinase domain mutations

著录项

相似文献

相关主题

期刊订阅